Transcription factor Efg1 shows a haploinsufficiency phenotype in modulating the cell wall architecture and immunogenicity of Candida albicans

Eukaryotic Cell

Volumn 11, Issue 2, 2012, Pages 129-140

  Zavrel, Martin ^a,c   Majer, Olivia ^b   Kuchler, Karl ^b   Rupp, Steffen ^a  

^a FRAUNHOFER INSTITUTE FOR INTERFACIAL ENGINEERING AND BIOTECHNOLOGY IGB   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; CANDIDA ALBICANS; CELL CULTURE; CELL WALL; GENETICS; HAPLOINSUFFICIENCY; IMMUNOLOGY; MACROPHAGE; METABOLISM; MOUSE; PHENOTYPE; PHYSIOLOGY;

ANIMALS; CANDIDA ALBICANS; CELL WALL; CELLS, CULTURED; FUNGAL PROTEINS; HAPLOINSUFFICIENCY; MACROPHAGES; MICE; PHENOTYPE; RNA, MESSENGER; TRANSCRIPTION FACTORS;

CANDIDA ALBICANS;

EID: 84856650946     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.05206-11     Document Type: Article

References (54)

1. Anderson J, Mihalik R, Soll DR. 1990. Ultrastructure and antigenicity of the unique cell wall pimple oftheCandida opaque phenotype. J. Bacteriol. 172:224-235.
2. Biswas S, Van Dijck P, Datta A. 2007. Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol. Mol. Biol. Rev. 71:348-376.
3. Bourgeois C, Majer O, Frohner IE, Tierney L, Kuchler K. 2010. Fungal attacks on mammalian hosts: pathogen elimination requires sensing and tasting. Curr. Opin. Microbiol. 13:401-408.
4. Care RS, Trevethick J, Binley KM, Sudbery PE. 1999. The MET3 promoter: a new tool for Candida albicans molecular genetics. Mol. Micro-biol. 34:792-798.
5. Chamilos G, et al. 2006. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J. Infect. Dis. 193:1014-1022.
6. DeLeo FR, Allen LA, Apicella M, Nauseef WM. 1999. NADPH oxidase activation and assembly during phagocytosis. J. Immunol. 163:6732-6740.
7. Dennehy KM, Willment JA, Williams DL, Brown GD. 2009. Reciprocal regulation ofIL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways. Eur. J. Immunol. 39:1379-1386.
8. Dieterich C, et al. 2002. In vitro reconstructed human epithelia reveal contributions of Candida albicans EFG1 and CPH1 to adhesion and invasion. Microbiology (Reading, England) 148:497-506.
9. Doedt T, et al. 2004. APSES proteins regulate morphogenesis and metabolism in Candida albicans. Mol. Biol. Cell 15:3167-3180.
10. d'Ostiani CF, et al. 2000. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med. 191:1661-1674.
11. Fonzi WA, Irwin MY. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728.
12. Forman HJ, Torres M. 2002. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am. J. Respir. Crit. Care Med. 166:S4-S8.
13. Fradin C, et al. 2005. Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol. Microbiol. 56:397-415.
14. Francois JM. 2006. A simple method for quantitative determination of polysaccharides in fungal cell walls. Nat. Protoc. 1:2995-3000.
15. Frohner IE, Bourgeois C, Yatsyk K, Majer O, Kuchler K. 2009. Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance. Mol. Microbiol. 71:240-252.
16. Fu Y, et al. 2002. Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway. Mol. Microbiol. 44:61-72.
17. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. 2003. Collaborative induction of inflammatory responses by dectin-1 and Tolllike receptor 2. J. Exp. Med. 197:1107-1117.
18. Gantner BN, Simmons RM, Underhill DM. 2005. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J. 24:1277-1286.
19. Gillum AM, Tsay EY, Kirsch DR. 1984. Isolation of the Candida albicans gene for orotidine-5' -phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. colipyrF mutations. Mol. Gen. Genet. 198:179-182.
20. Harcus D, Nantel A, Marcil A, Rigby T, Whiteway M. 2004. Transcription profiling of cyclic AMP signaling in Candida albicans. Mol. Biol. Cell 15:4490-4499.
21. Hiller E, Heine S, Brunner H, Rupp S. 2007. Candida albicans Sun41p, a putative glycosidase, is involved in morphogenesis, cell wall biogenesis, andbiofilm formation. Eukaryot. Cell 6:2056-2065.
22. Hnisz D, Majer O, Frohner IE, Komnenovic V, Kuchler K. 2010. The Set3/Hos2 histone deacetylase complex attenuates cAMP/PKA signaling to regulate morphogenesis and virulence of Candida albicans. PLoS Pat-hog. 6:e1000889.
23. Jackson BE, Wilhelmus KR, Hube B. 2007. The role of secreted aspartyl proteinases in Candida albicans keratitis. Invest. Ophthalmol. Vis. Sci. 48:3559-3565.
24. Korting HC, et al. 2003. Reduced expression of the hyphal-independent Candida albicans proteinase genes SAP1 and SAP3 in the efg1 mutant is associated with attenuated virulence during infection of oral epithelium. J. Med. Microbiol. 52:623-632.
25. Kvaal C, et al. 1999. Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. Infect. Immun. 67: 6652-6662.
26. Lay J, et al. 1998. Altered expression of selectable marker URA3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies. Infect. Immun. 66:5301-5306.
27. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
28. Lo HJ, et al. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949.
29. Lott JA, Turner K. 1975. Evaluation of Trinder's glucose oxidase method for measuring glucose in serum and urine. Clin. Chem. 21:1754-1760.
30. Lu Q, Jayatilake JA, Samaranayake LP, Jin L. 2006. Hyphal invasion of Candida albicans inhibits the expression of human beta-defensins in experimental oral candidiasis. J. Invest. Dermatol. 126:2049-2056.
31. Nantel A, et al. 2002. Transcription profiling of Candida albicans cells undergoing the yeast-to-hyphal transition. Mol. Biol. Cell 13:3452-3465.
32. Noffz CS, Liedschulte V, Lengeler K, Ernst JF. 2008. Functional mapping of the Candida albicans Efg1 regulator. Eukaryot. Cell 7:881-893.
33. Park H, et al. 2005. Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cell. Microbiol. 7:499-510.
34. Phan QT, Belanger PH, Filler SG. 2000. Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect. Immun. 68:3485-3490.
35. Phan QT, et al. 2007. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol. 5:e64.
36. Pietrella D, Bistoni G, Corbucci C, Perito S, Vecchiarelli A. 2006. Candida albicans mannoprotein influences the biological function of dendritic cells. Cell. Microbiol. 8:602-612.
37. Pukkila-Worley R, Peleg AY, Tampakakis E, Mylonakis E. 2009. Candida albicans hyphal formation and virulence assessed using a Caenorhab-ditis elegans infection model. Eukaryot. Cell 8:1750-1758.
38. Ramage G, VandeWalle K, Lopez-Ribot JL, Wickes BL. 2002. The filamentation pathway controlled by the Efg1 regulator protein isrequired for normal biofilm formation and development in Candida albicans. FEMS Microbiol. Lett. 214:95-100.
39. Raschke WC, Baird S, Ralph P, Nakoinz I. 1978. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15:261-267.
40. Roncero C, Duran A. 1985. Effect of calcofluor white and Congo red on fungal cell wall morphogenesis:in vivoactivationofchitin polymerization. J. Bacteriol. 163:1180-1185.
41. Rubin-Bejerano I, Abeijon C, Magnelli P, Grisafi P, Fink GR. 2007. Phagocytosis by human neutrophils is stimulated by a unique fungal cell wall component. Cell Host Microbe 2:55-67.
42. Saville SP, Thomas DP, Lopez Ribot JL. 2006. A role for Efg1p in Candida albicans interactions with extracellular matrices. FEMS Micro-biol. Lett. 256:151-158.
43. Schroppel K, et al. 2000. Repression of hyphal proteinase expression by the mitogen-activated protein (MAP) kinase phosphatase Cpp1p of Candida albicans is independent of the MAP kinase Cek1p. Infect. Immun. 68:7159-7161.
44. Setiadi ER, Doedt T, Cottier F, Noffz C, Ernst JF. 2006. Transcriptional response of Candida albicans to hypoxia: linkage of oxygen sensing and Efg1p-regulatory networks. J. Mol. Biol. 361:399-411.
45. Sharkey LL, Liao WL, Ghosh AK, Fonzi WA. 2005. Flanking direct repeats of hisG alter URA3 marker expression at the HWP1 locus of Candida albicans. Microbiology (Reading, England) 151:1061-1071.
46. Sharkey LL, McNemar MD, Saporito-Irwin SM, Sypherd PS, Fonzi WA. 1999. HWP1 functions in the morphological development of Candida albi-cans downstream of EFG1, TUP1, and RBF1. J. Bacteriol. 181:5273-5279.
47. Sohn K, Urban C, Brunner H, Rupp S. 2003. EFG1 is a major regulator of cell wall dynamics in Candida albicans as revealed by DNA microarrays. Mol. Microbiol. 47:89-102.
48. Sonneborn A, Bockmuhl DP, Ernst JF. 1999. Chlamydospore formation in Candida albicans requires the Efg1p morphogenetic regulator. Infect. Immun. 67:5514-5517.
49. Sonneborn A, et al. 2000. Protein kinase A encoded by TPK2 regulates dimorphism of Candida albicans. Mol. Microbiol. 35:386-396.
50. Sonneborn A, Tebarth B, Ernst JF. 1999. Control of white-opaque phe-notypic switching in Candida albicans by the Efg1p morphogenetic regulator. Infect. Immun. 67:4655-4660.
51. Srikantha T, Tsai LK, Daniels K, Soll DR. 2000. EFG1 null mutants of Candida albicans switch but cannot express the complete phenotype of white-phase budding cells. J. Bacteriol. 182:1580-1591.
52. Stoldt VR, Sonneborn A, Leuker CE, Ernst JF. 1997. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J. 16:1982-1991.
53. Weide MR, Ernst JF. 1999. Caco-2 monolayer as a model for transepi-thelial migration of the fungal pathogen Candida albicans. Mycoses 42(Suppl 2):61-67.
54. Wheeler RT, Fink GR. 2006. A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog. 2:e35.